Stay updated on INTRUST: Urelumab/Nivolumab Combo Clinical Trial
Sign up to get notified when there's something new on the INTRUST: Urelumab/Nivolumab Combo Clinical Trial page.

Latest updates to the INTRUST: Urelumab/Nivolumab Combo Clinical Trial page
- CheckyesterdayChange DetectedAdded a 2026 Clin Cancer Res publication on intratumoral urelumab with nivolumab; removed the earlier Clin Cancer Res citation (online ahead of print).SummaryDifference0.1%

- Check8 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. This appears to be an internal version update and does not alter study content or user-facing information.SummaryDifference0.0%

- Check44 days agoChange DetectedAdditions include two literature references and a revision notice, while deletions remove the corresponding errata and an earlier revision note; these changes affect bibliographic context but do not modify study design, eligibility criteria, or primary outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check51 days agoChange DetectedShow glossary toggle added; study record metadata updated to Revision 3.4.0 with QC fields adjusted (Last Update Submitted that Met QC Criteria and No FEAR Act Data). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check58 days agoChange DetectedPublication section updated with a new PubMed citation for the urelumab + nivolumab study and an auto-fill note indicating PubMed as the data source. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to INTRUST: Urelumab/Nivolumab Combo Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INTRUST: Urelumab/Nivolumab Combo Clinical Trial page.